Tag:
microplasmin
Latest Headlines
Latest Headlines
Positive data paves way for ThromboGenics trial
ThromboGenics is touting data from a Phase IIb trial of microplasmin for vitreous injection, saying it resolved the underlying disease in close to a third of all patients in one dosage group without
